Delivery Order SPE2DB22D1017-SPE2DB25FG0AC
Award Date
4/14/25
Potential Completion Date
4/15/25
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,287.68, is for the delivery of 4,567,956,474 units of the prescription medication lisdexamfetamine 40 mg capsules. The contract is a firm fixed-price, non-set-aside arrangement with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,648.60, is for the delivery of 4,567,914,253 units of the drug lisdexamfetamine 40 mg capsule. The contract is a firm fixed-price delivery order with an ultimate completion date of April 15, 2025. The contract was not set aside for any specific type of business. AmerisourceBergen holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,215.62 Firm Fixed Price delivery order is for the supply of 4,568,143,526 units of the prescription drug Lisdexamfetamine 50 mg capsules. The contract has an ultimate completion date of May 6, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,465.40, is for the delivery of 4,567,836,857 units of the medication lisdexamfetamine 50 mg capsules. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 9, 2025. There is no set-aside designation for this award. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,981.05 firm fixed-price delivery order is for the supply of 4,567,525,073 units of the drug Lisdexamfetamine 20 mg capsules. The contract has an ultimate completion date of March 11, 2025 and was awarded on March 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,382.80 fixed-price delivery order is for the supply of 4,568,225,703 units of the prescription medication lisdexamfetamine 10 mg capsules. The contract has a performance period through May 12, 2025 and is not set aside for any small business designation. AmerisourceBergen holds a substantial $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,650.71 firm fixed-price delivery order is for the supply of 4,566,893,252 units of the prescription drug lisdexamfetamine 40 mg capsules. The contract has an ultimate completion date of January 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,568,185,890 units of the medication lisdexamfetamine 50 mg capsule in 100-count packages. The $2,584.29 firm fixed-price delivery order has a completion date of May 9, 2025 and is not a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,315.24 firm fixed-price delivery order is for the supply of 4,568,247,969 units of lisdexamfetamine 40 mg capsules. The contract has an ultimate completion date of May 15, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,426.88, is for the delivery of 4,567,422,819 units of 40 mg lisdexamfetamine capsules. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...